Lower-risk Myelodysplastic Syndromes: Clinical Trials

1 trial for Lower-risk Myelodysplastic Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow Lower-risk Myelodysplastic Syndromes: new trials by email Literature Review of Lower-risk Myelodysplastic Syndromes trials Research Report on Lower-risk Myelodysplastic Syndromes

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
rhTPO + CsA vs CsA in the Treatment of LR-MDS With Thrombocytopenia
rhTPO, Cyclosporine (CsA) - Lower-risk Myelodysplastic Syndromes
Phase 3Not yet recruitingPeking Union Medical College Hospital782026-06-012026-06-17

Interventions

Cyclosporine (1)

Sponsors

Peking Union Medical College Hospital (1)